MANILA, Philippines — The Food and Drug Administration’s (FDA) advisory for China-made CoronaVac of Sinovac Biotech may change if new data supports that the COVID-19 jab is safe for senior citizens.
Health Secretary Francisco Duque III said this Wednesday, explaining that while he is yet to receive any new advisory from Sinovac regarding the use of Coronavac for the elderly, FDA can alter its previous notice on the vaccine.
FDA previously advised against using CoronaVac for seniors or those aged above 60 in the absence of a concrete study on its use for the said age range, and since its efficacy rate is lower compared to other COVID-19 shots.
“Hindi ko alam kung merong bagong …
Keep on reading: Duque: FDA may revise Sinovac jab advisory if data backs vaccination for seniors